Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2014
Total Assets: $41.21B
Liabilities Breakdown FY2014
Total Liabilities: $19.68B
Asset Breakdown
Total Assets: $41.21B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.06B | 9.9% |
| Accounts Receivable | $3.59B | 8.7% |
| Inventory | $2.64B | 6.4% |
| Property, Plant & Equipment | $5.94B | 14.4% |
| Goodwill | $10.07B | 24.4% |
| Intangible Assets | $6.20B | 15.0% |
| Other Assets | $8.72B | 21.1% |
Liabilities Breakdown
Total Liabilities: $19.68B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.06B | 5.4% |
| Long-Term Debt | $3.39B | 17.2% |
| Other Liabilities | $15.22B | 77.4% |